INTRODUCTION
============

Smokers try to stop smoking but many of them fail to stop smoking. The major cause of fail to stop smoking is the nicotine dependence. Nicotine dependence is associated with several neurotransmitters, such as dopamine, noradrenaline, 5-hydroxytryptamine, acetylcholine, etc. ([@b8-jer-15-3-383]). Nicotine withdrawal symptoms comprise insomnia, depression, anxiety, attention disorders, and increased craving ([@b2-jer-15-3-383]; [@b13-jer-15-3-383]). Antidepressive or antianxiety medications are often administered with nicotine withdrawal medication. For example, selective serotonin reuptake inhibitors inhibit the reuptake of neurotransmitters and increase serotonin and dopamine levels, thereby reduce anxiety, stress, and depression in nicotine-addicted patients ([@b11-jer-15-3-383]). Nicotine withdrawal reduces hippocampal-dependent learning ability ([@b6-jer-15-3-383]; [@b12-jer-15-3-383]) which is associated with change in hippocampal nicotinic acetylcholine receptor ([@b9-jer-15-3-383]).

Serotonin (5-hydroxytryptamine, 5-HT) is a monoamine neurotransmitter, which acts as the biochemical messenger and regulator for the brain function ([@b16-jer-15-3-383]; [@b17-jer-15-3-383]). As tryptophan hydroxylase (TPH) is the rate-limiting enzyme for the synthesis of 5-HT, reduction in TPH causes a rapid decrease of 5-HT level ([@b17-jer-15-3-383]). 5-HT and TPH are involved in the mood regulation ([@b5-jer-15-3-383]).

Brain-derived neurotrophic factor (BDNF) and its receptor, tyrosine kinase B (TrkB), are widely expressed in the mammalian brain. Hippocampal BDNF is known to be increased by learning and exercise ([@b4-jer-15-3-383]; [@b10-jer-15-3-383]). BDNF expression induced by exercise increases neurogenesis and enhances long-term potentiation of the hippocampus ([@b7-jer-15-3-383]). BDNF/TrkB signaling modulates neuronal survival, morphogenesis, and plasticity ([@b21-jer-15-3-383]).

Neurogenesis is a process of generating functional neurons from progenitor cells, comprising proliferation, maturation, and functional integration into neuronal circuits. Developing neurons express several markers during maturation process. Detection of 5- bromo-2′-deoxyuridine (BrdU) by immunohistochemistry has been used for phenotypic analysis and stereological quantification of newly formed neurons ([@b15-jer-15-3-383]; [@b14-jer-15-3-383]). Neuronal nuclear (NeuN) antigen is regarded as the useful marker of neuronal maturation ([@b15-jer-15-3-383]; [@b14-jer-15-3-383]). Doublecortin (DCX) is a marker of neuronal precursor cells, and DCX is implicated in the neuronal migration and development ([@b15-jer-15-3-383]; [@b18-jer-15-3-383]).

The effect of exercise on neuropyshicatric disorders are well documented ([@b4-jer-15-3-383]; [@b18-jer-15-3-383]; [@b19-jer-15-3-383]; [@b27-jer-15-3-383]). The possibility of exercise to help the cessation of smoking was suggested ([@b28-jer-15-3-383]). In the present study, we evaluated the effect of treadmill exercise on nicotine withdrawal-induced symptoms.

MATERIALS AND METHODS
=====================

Experiment animals
------------------

This study was approved by the Kyung Hee University Institutional Animal Care and Use Committee (Seoul, Korea) (KHUASP \[SE\]-16-152). Male Sprague-Dawley rats (8 weeks old and 200-g weight) were randomly divided into four groups: control group, control with exercise group, nicotine withdrawal group, and nicotine withdrawal with exercise group.

Nicotine injection and withdrawal
---------------------------------

The rats in the nicotine withdrawal groups received subcutaneous injection with 6-mg/kg nicotine hydrogen tartrate salt (Sigma-Aldrich, St. Louis, MO, USA) for 17 days. And then, the injection of nicotine hydrogen tartrate salt was stopped next 2 weeks.

Treadmill exercise
------------------

The rats in the exercise groups performed treadmill running for 5 min at 8 m/min, for 5 min at 11 m/min, for 30 min at 14 m/min, and for 5 min at 3 m/min, with 0 inclination. This running was conducted once a day, five days per week, for 31 days.

Open field test
---------------

We determined the activity of rats using open field test, according to the previous method ([@b27-jer-15-3-383]). The animals were placed in a white square open field arena made of wood. It was enclosed with 40-cm-high walls and placed under strong illumination (200 Lx). The arena was divided into 16 squares, defined as 4 central and 12 peripheral squares. The animal was placed in the center of the arena and left free to explore the environment for 1 min. After that time, the number of squares that the rat crossed was recorded for 5 min.

Elevated plus-maze test
-----------------------

Anxiety-like behavior was evaluated using the elevated plus-maze test, according to the previous method ([@b27-jer-15-3-383]). The elevated plus-maze test consisted of two opposing open arms (45 cm×10 cm) and two closed arms (45 cm×10 cm×50 cm) that extended from a central platform (10 cm×10 cm), elevated 65 cm above the floor. Each rat was placed on the central platform facing a closed arm, and was allowed to freely explore the maze for 5 min. Entry into an arm was defined as entry of all four paws into the arm. The time spent in the open arms and the percentage of the entries into the open arms during 5 min were calculated.

Step-down avoidance test
------------------------

In order to evaluate short-term memory, the latency in the step-down avoidance test was measured, according to the previous method ([@b3-jer-15-3-383]). The animals were positioned on a 7×25-cm platform with a height of 2.5 cm, and then allowed to rest on the platform for 2 min. The platform faced a 42×25-cm grid of parallel 0.1-cm caliber stainless steel bars, which were spaced 1 cm apart. In the training session, the animals received 0.3-mA scramble foot shock for 2 sec immediately upon stepping down. Latency time was assessed after 24 hr of training session. The interval of rats stepping down and placing all four paws on the grid was defined as the latency time. The latency over 300 sec was counted as 300 sec.

Morris water maze test
----------------------

Spatial learning ability was evaluated using the Morris water maze test, according to the previous method ([@b22-jer-15-3-383]). This task requires rats to learn the spatial location of a hidden platform in a black circular pool (180-cm diameter and 50-cm height) filled with clear water (25°C±1°C). The hidden platform (15-cm diameter and 40-cm height) was placed 2 cm below the surface of water in the middle of the north quadrant and was camouflaged by virtue of being transparent against a black background. Distal visual cues were placed on the walls around the pool. The position of the cues remained unchanged through the task. All rats were trained three times a day for four consecutive days before Morris water maze test.

Morris water maze test was conducted 24 hr after the last training. When finding the platform, the rats were allowed to remain for 30 sec. If the rats did not find the platform within 60 sec, they were guided by hand to the platform. The rats were given 60-sec retention probe test, and then the platform removed from the pool. Data were automatically collected via the Smart Video Tracking System (Smart ver. 2.5, Panlab, Barcelona, Spain).

Tissue preparation
------------------

The rats were sacrificed immediately after last behavior test. After anesthetizing using Zoletil 50 (10 mg/kg, intraperitoneally; Vibac Laboratories, Carros, France), the rats were transcardially perfused with 50 mM phosphate-buffered saline (PBS) and were fixed with 4% paraformaldehyde in 100 mM phosphate buffer (PB, pH 7.4). The brains were dissected and post-fixed in the same fixative overnight and transferred into a 30% sucrose solution for cryoprotection. Using a freezing microtome (Leica, Nussloch, Germany), 40-μm-thick sagittal sections were made.

Immunohistochemistry for DCX
----------------------------

Immunohistochemistry for DCX was performed, according to the previous method ([@b22-jer-15-3-383]). The sections were incubated in PBS for 10 min, washed three times in PBS, and then incubated in 1% hydrogen peroxide for 20 min. The sections were incubated 2 hr with goat anti-DCX antibody (1:1,000; Oncogene Research Product, Cambridge, UK). The sections were then incubated with the biotinylated goat secondary antibody (1:500; Vector Laboratories, Burlingame, CA, USA) for another 1 hr, washed, and incubated in ABC complex (Vector Elite ABC kit; 1:100; Vector Laboratories). Labeling was visualized using 0.03% diaminobenzidine, and the sections were mounted onto gelatin-coated slides. The slides were air-dried overnight at room temperature, and the coverslips were mounted using Permount (Thermo Fisher Scientific Inc., Waltham, MA, USA).

Immunohistochemistry for BrdU
-----------------------------

Immunohistochemistry for BrdU was performed, according to the previous method ([@b3-jer-15-3-383]). The sections were first permeabilized by incubation in 0.5% Triton X-100 in PBS for 20 min, then pretreated in 50% formamide-2X standard saline citrate at 65°C for 2 hr, denatured in 2 N HCl at 37°C for 30 min, and rinsed twice in 100 mM sodium borate (pH, 8.5). The sections were then incubated overnight at 4°C with BrdU-specific mouse monoclonal antibody (1:600; Roche, Mannheim, Germany). The sections were then washed three times with PBS and incubated with biotinylated mouse secondary antibody (1:200; Vector Laboratories) for 1 hr. The sections were then incubated for 1 hr with an ABC complex (1:100; Vector Laboratories). For visualization, the sections were incubated in 50 mM Tris-HCl (pH, 7.6) containing 0.03% diaminobenzidine, 40-mg/mL nickel chloride, and 0.03% hydrogen peroxide for 5 min.

After BrdU labeling, a mouse antineuronal nuclei antibody (1:1,000; Chemicon International, Temecula, CA, USA) was used on the same sections to differentiate neurons. The sections were washed 3 times with PBS, incubated for l hr with a biotinylated anti-mouse secondary antibody. For staining, the sections were incubated in a reaction mixture consisting of 0.03% diaminobenzidine and 0.03% hydrogen peroxide for 5 min. The sections were mounted onto gelatin-coated slides, air-dried overnight at room temperature, and coverslips were mounted using Permount (Thermo Fisher Scientific Inc.).

Immunohistochemistry for TPH and 5-HT
-------------------------------------

Immunohistochemistry was performed for the detection of the TPH-positive and 5-HT-positive cells in the dorsal raphe, according to the previous method ([@b20-jer-15-3-383]). The sections were incubated in PBS for 10 min and they were next washed 3 times with PBS. The sections were then incubated in 1% hydrogen peroxide for 30 min, and then they were incubated overnight with mouse anti-TPH antibody (Oncogene Research Product) and rabbit anti-5-HT antibody (Oncogene Research Product) at a dilution of 1:500 for TPH and 5-HT expressions. The sections were incubated for 90 min with biotinylated mouse secondary antibody and with biotinylated rabbit secondary antibody (Vector Laboratories), and they were subsequently incubated with avidin-biotin-peroxidase complex (Vector Laboratories) for 1 hr. Immunoreactivity was visualized by incubating the sections in a solution consisting of 0.05% 3,3′-diaminobenzidine and 0.01% hydrogen peroxide in 50 mM Tris-buffer (pH, 7.6) for approximately 3 min. The sections were finally mounted on gelatin-coated glass slides. The slides were air-dried overnight at room temperature, and the coverslips were mounted using Permount (Thermo Fisher Scientific Inc.).

Western blotting for BDNF and TrkB
----------------------------------

Western blotting for the determination of BDNF and TrkB was conducted, according to the previous method ([@b22-jer-15-3-383]). Hippocampal samples were homogenized on ice and lysed in a lysis buffer containing 50 mM Tris-HCl (pH, 7.5), 150 mM NaCl, 0.5% deoxycholic acid, 1% Nonidet P40, 0.1% sodium dodecyl sulfate (SDS), 1 mM phenylmethylsulfonyl fluoride, and 100 mg/mL leupeptin. Protein content was measured using a Bio-Rad colorimetric protein assay kit (Bio-Rad, Hercules, CA, USA). Thirty micrograms of total protein were separated on SDS-polyacrylamide gels and transferred onto a nitrocellulose membrane. The membrane was blocked with dehydrated milk, then incubated with mouse anti-β-actin antibody (1:1,000; Santa Cruz Biotechnology, Santa Cruz, CA, USA), rabbit anti-BDNF antibody (1:1,000; Santa Cruz Biotechnology), and rabbit anti-TrkB antibody (1:1,000; Santa Cruz Biotechnology). After washing, horseradish peroxidase-conjugated, appropriate secondary antibodies were applied. Incubations were performed at room temperature. The bands were detected using the enhanced chemiluminescence detection system (Santa Cruz Biotechnology), and quantified using an Image-Pro Plus computer-assisted image analysis system (Media Cyberbetics Inc., Silver Spring, MD, USA).

Statistical analysis
--------------------

Data were analyzed using IBM SPSS Statistics ver. 21.0 (IBM Co., Armonk, NY, USA). The results were expressed as the mean±standard error of the mean. One-way analysis of variance with Tukey *post hoc* test was used for comparison among the groups. *P*\<0.05 was considered significant.

RESULTS
=======

Behavior test
-------------

[Fig. 1](#f1-jer-15-3-383){ref-type="fig"} shows the results of behavior test in the nicotine withdrawal rats. Activity was measured using the open field test ([Fig. 1A, B](#f1-jer-15-3-383){ref-type="fig"}). Activity scores in the center and total were decreased in the rats of the nicotine withdrawal group (*P*\<0.05), in contrast, treadmill exercise increased scores in the rats of the nicotine withdrawal group (*P*\<0.05). Anxiety-like symptoms were measured using the elevated plus-maze test ([Fig. 1C, D](#f1-jer-15-3-383){ref-type="fig"}). Open arms entries and times were decreased in the rats of the nicotine withdrawal group (*P*\<0.05), in contrast, treadmill exercise increased symptoms in the rats of the nicotine withdrawal group (*P*\<0.05). Short-term memory was measured using the step-down avoidance test ([Fig. 1E](#f1-jer-15-3-383){ref-type="fig"}). Latency was decreased in the rats of the nicotine withdrawal group (*P*\<0.05), in contrast, treadmill exercise increased latency in the rats of the nicotine withdrawal group (*P*\<0.05). Spatial learning ability was measured using the Morris water maze test ([Fig. 1F](#f1-jer-15-3-383){ref-type="fig"}). Time in probe quadrant was decreased in the rats of the nicotine withdrawal group (*P*\<0.05), in contrast, treadmill exercise increased this time in the rats of the nicotine withdrawal group (*P*\<0.05).

The numbers of TPH-positive and 5-HT-positive cells in the dorsal raphe
-----------------------------------------------------------------------

[Fig. 2](#f2-jer-15-3-383){ref-type="fig"} shows the numbers of TPH-positive ([Fig. 2A, C](#f2-jer-15-3-383){ref-type="fig"}) and 5-HT-positive cells ([Fig. 2B, D](#f2-jer-15-3-383){ref-type="fig"}) in the dorsal raphe. The numbers of TPH-positive and 5-HT-positive cells were decreased in the rats of the nicotine withdrawal group (*P*\<0.05), in contrast, treadmill exercise increased these numbers in the rats of the nicotine withdrawal group (*P*\<0.05).

The numbers of DCX-positive and BrdU-positive cells in the dentate gyrus
------------------------------------------------------------------------

[Fig. 3](#f3-jer-15-3-383){ref-type="fig"} shows the numbers of DCX-positive ([Fig. 3A, C](#f3-jer-15-3-383){ref-type="fig"}) and BrdU-positive cells ([Fig. 3B, D](#f3-jer-15-3-383){ref-type="fig"}) in the dentate gyrus. The numbers of DCX-positive and BrdU-positive cells were decreased in the rats of the nicotine withdrawal group (*P*\<0.05), in contrast, treadmill exercise increased these numbers in the rats of the nicotine withdrawal group (*P*\<0.05).

Expressions of BDNF and TrkB in hippocampus
-------------------------------------------

[Fig. 4](#f4-jer-15-3-383){ref-type="fig"} shows the expressions of BDNF ([Fig. 4B](#f4-jer-15-3-383){ref-type="fig"}) and TrkB ([Fig. 4C](#f4-jer-15-3-383){ref-type="fig"}) in the hippocampus. BDNF and TrkB expressions were decreased in the rats of the nicotine withdrawal group (*P*\<0.05), in contrast, treadmill exercise increased these expressions in the rats of the nicotine withdrawal group (*P*\<0.05).

DISCUSSION
==========

In the present results, activity was decreased and anxiety-like behavior was observed in the nicotine withdrawal rats. Treadmill running increased activity and ameliorated anxiety-like behavior in the nicotine-withdrawal rats. Under the certain conditions, nicotine acted as anxiolytic and antidepressant. If adaptation to nicotine occurs following chronic nicotine use, nicotine withdrawal caused anxiety and depression ([@b24-jer-15-3-383]). Exercise was suggested as the effective adjunct in lessening the nicotine withdrawal symptoms ([@b28-jer-15-3-383]). Treadmill exercise exerted ameliorating effect on severity of anxiety and depression ([@b4-jer-15-3-383]; [@b27-jer-15-3-383]).

In the present results, expressions of TPH and 5-HT in the dorsal raphe were decreased in the nicotine withdrawal rats. Expressions of TPH and 5-HT were increased by treadmill running in the nicotine withdrawal rats. Decreased activity of the brain serotonergic system was implicated in the pathophysiology of depression ([@b1-jer-15-3-383]). 5-HT level was closely associated with depression and adult neurogenesis ([@b17-jer-15-3-383]; [@b20-jer-15-3-383]). Treadmill running enhanced expressions of 5-HT and TPH in the dorsal raphe of the social isolation-induced depressive rats ([@b4-jer-15-3-383]).

In the present results, impaired short-term memory and deteriorated spatial learning ability were appeared in the nicotine withdrawal rats. Treadmill running ameliorated impairment of short-term memory and spatial learning ability in the nicotine withdrawal rats. Smoking cessation caused a decline of learning ability and attention ([@b6-jer-15-3-383]). Learning ability was decreased after the cessation of chronic nicotine administration because of altered nicotine receptor in the hippocampus ([@b12-jer-15-3-383]).

In the present results, expressions of BDNF and TrkB were decreased in the nicotine withdrawal rats. Expressions of BDNF and TrkB were increased by treadmill running in the nicotine withdrawal rats. BDNF has been suggested as a principal mediator of exercise on the overall brain function. Reduction of BDNF was closely related with decrease of neurogenesis ([@b25-jer-15-3-383]). Reduction of BDNF and decreased neurogenesis were restored by exercise ([@b4-jer-15-3-383]; [@b26-jer-15-3-383]).

In the present results, the numbers of the DCX-positive cells and BrdU-positive cells in the dentate gyrus were suppressed in the nicotine withdrawal rats. These numbers were enhanced by treadmill running in the nicotine withdrawal rats. Reduced cell proliferation in the dentate gyrus was associated with the impairment of learning and memory function, in contrast, increased cell proliferation is associated with the improvement of learning and memory function ([@b4-jer-15-3-383]; [@b14-jer-15-3-383]). Exercise increased neurogenesis, and then improved memory function ([@b4-jer-15-3-383]; [@b15-jer-15-3-383]; [@b14-jer-15-3-383]).

The present study demonstrated that treadmill exercise ameliorated nicotine withdrawal-induced anxiety and depression through enhancing 5-HT synthesis in the brain. Treadmill exercise improved memory function against nicotine withdrawal-induced memory impairment through enhancing neurogenesis in the brain. Based on the present results, treadmill exercise can be recommended as the adjunctive treatment to reduce nicotine withdrawal-induced symptoms.

**CONFLICT OF INTEREST**

No potential conflict of interest relevant to this article was reported.

This study was supported by the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF-2016S1A5A2A01023254).

![Behavior test. (A, B) Open field test. (C, D) Elevated plus maze test. (E) Step-down avoidance test. (F) Morris water maze test. CON, control group; CON+EX, control with exercise group; NCT, nicotine withdrawal group; NCT+EX, nicotine withdrawal with exercise group. \**P*\<0.05 compared to control group. ^\#^*P*\<0.05 compared to nicotine withdrawal group.](jer-15-3-383f1){#f1-jer-15-3-383}

![Tryptophan hydroxylase (TPH) and 5-hydroxytryptamine (5-HT) in the dorsal raphe. (A) Photomicrographs of TPH. (C) The number of TPH-positive cells in each group. (B) Photomicrographs of 5-HT. (D) The number of 5-HT-positive cells in each group. The scale bar represents 200 μm. CON, control group; CON+EX, control with exercise group; NCT, nicotine withdrawal group; NCT+EX, nicotine withdrawal with exercise group. \**P*\<0.05 compared to control group. ^\#^*P*\<0.05 compared to nicotine withdrawal group.](jer-15-3-383f2){#f2-jer-15-3-383}

![Cell differentiation and cell proliferation in the dentate gyrus. (A) Photomicrograph of doublecortin (DCX)-positive cells. (C) The number of DCX-positive cells in each group. (B) Photomicrograph of 5-bromo-2′-deoxyuridine (BrdU)-positive cells. (D) The number of BrdU-positive cells in each group. The scale bar represents 500 μm in each group. CON, control group; CON+EX, control with exercise group; NCT, nicotine withdrawal group; NCT+EX, nicotine withdrawal with exercise group. \**P*\<0.05 compared to control group. ^\#^*P*\<0.05 compared to nicotine withdrawal group.](jer-15-3-383f3){#f3-jer-15-3-383}

![Brain-derived neurotrophic factor (BDNF) and tyrosine kinase B (TrkB) in the hippocampus. (A) Presentation of BDNF and TrkB expressions. (B) Relative optical density of BDNF in each group. (C) Relative optical density of TrkB in each group. CON, control group; CON+EX, control with exercise group; NCT, nicotine withdrawal group; NCT+EX, nicotine withdrawal with exercise group. \**P*\<0.05 compared to control group. ^\#^*P*\<0.05 compared to nicotine withdrawal group.](jer-15-3-383f4){#f4-jer-15-3-383}
